Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (451-460 of 941) with videos related to

Pageof 95
Sort By:
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Oncotarget|January 23, 2014
GATA2 as a potential metastasis-driving gene in prostate cancerYan Ting Chiang, Kendric Wang, Ladan Fazli, et al.
The British Journal of Surgery|April 1, 1974
Proceedings: Feasibility of screening the population at risk from breast cancerE N Gleave, R A Sellwood, P C England, et al.
Proceedings of the Royal Society of Medicine|June 1, 1970
Radioactive implants of the pituitary for endocrine diseaseA P Forrest, J P Thomas, S H Richards, et al.
The Prostate|March 9, 2005
pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing miceEmma S Guns, Xiaowei Xie, Matthew Fedoruk, et al.
Applied Psychophysiology and Biofeedback|September 2, 2024
A Systematic Review of the Relationship Between Traumatic Brain Injury and Disruptions in Heart Rate VariabilityLeah D Talbert, Zoey Kaelberer, Emma Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancerBernhard J C Eigl, Scott E Eggener, Jenny Baybik, et al.
Cancer Research|May 19, 2007
DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cellsJ Erin Tillman, Jialing Yuan, Guangyu Gu, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Pageof 95

Showing results (451-460 of 941) with videos related to

Sort By:
Pageof 95
The Journal of Urology|August 18, 2004
Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancerG L Andriole, P Humphrey, P Ray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
A phase II pharmacodynamic study of preoperative figitumumab in patients with localized prostate cancerKim N Chi, Martin E Gleave, Ladan Fazli, et al.
Oncotarget|January 23, 2014
GATA2 as a potential metastasis-driving gene in prostate cancerYan Ting Chiang, Kendric Wang, Ladan Fazli, et al.
The British Journal of Surgery|April 1, 1974
Proceedings: Feasibility of screening the population at risk from breast cancerE N Gleave, R A Sellwood, P C England, et al.
Proceedings of the Royal Society of Medicine|June 1, 1970
Radioactive implants of the pituitary for endocrine diseaseA P Forrest, J P Thomas, S H Richards, et al.
The Prostate|March 9, 2005
pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing miceEmma S Guns, Xiaowei Xie, Matthew Fedoruk, et al.
Applied Psychophysiology and Biofeedback|September 2, 2024
A Systematic Review of the Relationship Between Traumatic Brain Injury and Disruptions in Heart Rate VariabilityLeah D Talbert, Zoey Kaelberer, Emma Gleave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancerBernhard J C Eigl, Scott E Eggener, Jenny Baybik, et al.
Cancer Research|May 19, 2007
DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cellsJ Erin Tillman, Jialing Yuan, Guangyu Gu, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2013
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout miceK Takahara, N Ibuki, M Ghaffari, et al.
Pageof 95